Company Profile
WuXi AppTec Co., Ltd., an investment holding company provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and globally.
Its operations are structured into WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities
Including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic laboratory testing services, such as toxicology, DMPK, and bioanalytical services.
Its portfolio also includes clinical contract research organization services Including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics, and site management organization, patient recruitment, site start-up, and academic research organization. Additionally, it offers services for biology.
Its portfolio also includes CDRMO platform for small molecules, oligonucleotides, and peptides, drug R&D testing, and clinical research services. Founded in 2000, WuXi AppTec is headquartered in Shanghai, the People's Republic of China.